Manager TitleAgeSince
Corporate Secretary - 2019-06-12
Human Resources Officer 53 2015-12-10
Director TitleAgeSince
Director/Board Member 74 2010-04-08
Director/Board Member 49 2016-03-29
Chairman 72 2017-03-29
Date Insider Type Main position Quantity % Market Cap.
21-04-26OtherCompany 1,452,000 0.3656%
21-04-25OtherCompany 748,000 0.1883%
21-04-20OtherCompany 1,526,000 0.3842%
Change 5-day change 1-year change 3-year change Capi.($)
+40.94%+1.70% - - 96.5M
-2.65%-1.37%+49.71%+161.20% 1,085B
-1.26%-1.30%+62.32%+60.47% 624B
-1.50%-3.40%+26.21%+82.99% 442B
+0.33%-1.17%+27.98%+26.90% 332B
-3.89%-11.22%+20.78%+26.07% 277B
-0.02%-2.85%+25.27%+44.88% 282B
+0.66%-1.42%-29.26%-39.30% 217B
-0.09%-0.84%+20.97%+61.69% 196B
-3.69%+0.15%+13.33%+71.50% 167B
Average +2.82%-1.86%+24.15%+55.16% 402.44B
Weighted average by Cap. -1.67%-1.06%+34.94%+81.08%
Logo Lansen Pharmaceutical Holdings Limited
Lansen Pharmaceutical Holdings Limited is a Hong Kong-based investment holding company principally engaged in pharmaceutical businesses. The Company operates through three segments. Specialty Pharmaceuticals segment is engaged in the development, production and sales of specialty pharmaceuticals mainly used in the fields of rheumatology and dermatology. Its main specialty pharmaceutical products include pafulin, leflunomide tablets and mycophenolate mofetil dispersible tablets. Plant Extract and Healthcare Products segment is engaged in the development, production and sales of Chinese medicine extracts and healthcare products. Other Pharmaceuticals segment is engaged in businesses related to other pharmaceuticals.
Employees
652